Earlier this month, the FDA published a Discussion Paper titled “Health Equity for Medical Devices”. According to the CDC, Health Equity is “the...
PRP Consulting Team
Recent Posts
Important MDSAP Updates
On August 6, 2024, the Audit Approach document under the Medical Device Single Audit Program (“MDSAP”) was updated to Version 009. As a reminder,...
Latest FDA Guidance on Medical Device AI
The impact of Artificial Intelligence (“AI”) is being seen throughout society, and the medical device community is no exception. Regulatory bodies...
FDA's eMDR System Enhancements for 2024
The FDA recently announced its planned enhancements to the Electronic Medical Device Reporting (eMDR) System. The purpose of the announcement was to...
The Latest from FDA on Biocompatibility
Earlier this year, the FDA’s Center for Devices and Radiological Health (“CDRH”) published a new public dataset to assist chemistry laboratories in...
FDA Moves Forward on Laboratory Developed Tests
Following years of discussion and debate, the FDA officially published its final rule covering laboratory developed tests (“LDTs”) on May 6, 2024....
Latest on In Vitro Diagnostic Regulations
On April 25, 2024, the European Commission issued a press release announcing that additional time will be granted to companies to transition to the...